RESPIRATORY PAPILLOMA

This adverse event was reported 55 times

RESPIRATORY PAPILLOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CIDOFOVIR ANHYDROUS 8 0.0055
1 ERLOTINIB HYDROCHLORIDE 12 0.0010
2 BEVACIZUMAB-AWWB 1 0.0002
3 BICALUTAMIDE 3 0.0002
4 BEVACIZUMAB 22 0.0002
5 TIGECYCLINE 1 0.0002
6 CLARITHROMYCIN 3 0.0001
7 CELECOXIB 11 0.0001
8 MYCOPHENOLATE MOFETIL 9 0.0001
9 TACROLIMUS OINTMENT 0.1% 8 0.0001
See all drugs enriched for association with RESPIRATORY PAPILLOMA